Prudential Financial’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,737
Closed -$383K 2320
2024
Q4
$383K Sell
20,737
-1,150
-5% -$22.5K ﹤0.01% 1923
2024
Q3
$476K Sell
21,887
-650
-3% -$14.5K ﹤0.01% 2241
2024
Q2
$442K Sell
22,537
-700
-3% -$14.6K ﹤0.01% 2238
2024
Q1
$504K Buy
23,237
+20
+0.1% +$497 ﹤0.01% 2170
2023
Q4
$671K Sell
23,217
-674
-3% -$18K ﹤0.01% 2006
2023
Q3
$639K Sell
23,891
-57,700
-71% -$1.97M ﹤0.01% 1967
2023
Q2
$3.02M Sell
81,591
-11,148
-12% -$389K ﹤0.01% 1175
2023
Q1
$2.9M Sell
92,739
-7,550
-8% -$243K ﹤0.01% 1113
2022
Q4
$2.99M Buy
100,289
+12,200
+14% +$437K 0.01% 1114
2022
Q3
$3.36M Buy
88,089
+14,605
+20% +$732K 0.01% 1034
2022
Q2
$4.01M Buy
73,484
+20,855
+40% +$1.15M 0.01% 999
2022
Q1
$3.28M Buy
52,629
+20,688
+65% +$1.36M ﹤0.01% 1218
2021
Q4
$3.21M Sell
31,941
-6,863
-18% -$603K ﹤0.01% 1285
2021
Q3
$3.49M Sell
38,804
-6,336
-14% -$576K ﹤0.01% 1176
2021
Q2
$4.16M Buy
45,140
+25,163
+126% +$2.01M 0.01% 1107
2021
Q1
$1.93M Buy
19,977
+4,947
+33% +$511K ﹤0.01% 1477
2020
Q4
$783K Buy
15,030
+1,310
+10% +$54.7K ﹤0.01% 1869
2020
Q3
$549K Buy
+13,720
New +$429K ﹤0.01% 1918

Other funds holding FLGT

Prudential Financial's FLGT Position: Q1 2025 in Review

Prudential Financial sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 20,737 shares — an estimated $383K sold.

Prudential Financial first reported a position in FLGT in Q3 2020 and held it in 18 quarters. The position peaked at $4.16M in Q2 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Prudential Financial reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Prudential Financial sold 20,737 Fulgent Genetics shares in Q1 2025, an estimated $383K.
  • Prudential Financial first reported a position in Fulgent Genetics in Q3 2020 and held it in 18 quarters.
  • Prudential Financial's Fulgent Genetics position peaked at $4.16M in Q2 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Prudential Financial's 13F filing for Q1 2025, filed 13 May 2025.